Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Contraception
Conditions
Contraception
Trial Timeline
Feb 1, 2003 → Oct 1, 2005
NCT ID
NCT00245921About Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg
Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg is a phase 3 stage product being developed by Pfizer for Contraception. The current trial status is completed. This product is registered under clinical trial identifier NCT00245921. Target conditions include Contraception.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00245921 | Phase 3 | Completed |
Competing Products
20 competing products in Contraception